Targeted therapy for NSCLC with EGFR mutations, Third-generation irreversible EGFR-TKI, Inhibits EGFR Ex19Del and L858R mutations, Active against CNS metastases, Effective for EGFRm NSCLC patients,
Sale!
Lucius
Replica Osimertinib EGFRm NSCLC Therapy
Original price was: $558.00.$399.00Current price is: $399.00.
Targeted therapy for NSCLC with EGFR mutations, Third-generation irreversible EGFR-TKI, Inhibits EGFR Ex19Del and L858R mutations, Active against CNS metastases, Effective for EGFRm NSCLC patients,
Reviews
There are no reviews yet.